Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MGM Resorts International (MGM) vs Smith & Nephew plc (SNN) Price & Performance

MGM Resorts InternationalTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

MGM Resorts International vs Smith & Nephew plc — how do they compare? MGM Resorts International trades at $40.55 (market cap $10.25B), while Smith & Nephew plc trades at $27.72 (market cap $11.63B). The key difference: MGM Resorts International and Smith & Nephew plc are close in size by market cap, and Smith & Nephew plc pays the higher dividend (2.85%). Which is the better fit depends on your goals.

MGMSNN
Market Cap
$10.25B$11.63B
Sector
Consumer CyclicalHealth
52-Week High
$50.69$38.53
52-Week Low
$30.72$27.80
Enterprise Value
$37.55B$14.66B
Dividend Yield
0.03%2.85%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MGM Resorts International

MGM Resorts International (MGM) trades at $40.74, down 1.16% on the day, with a bearish technical signal but bullish oscillators like RSI indicating potential oversold conditions. Revenue grew to $17.54B in 2025, though net income margin compressed to 2.4%. Recent news includes a $48.30 per share acquisition offer under investigation and BetMGM's football season enhancements, reflecting mixed operational and strategic developments.

The stock presents a valuation opportunity with a low P/S of 0.61 and strong analyst consensus price target of $51.61, but faces risks from declining profitability, high debt, and regulatory scrutiny. Upside hinges on execution in digital and international segments, while investor sentiment is cautious amid earnings volatility and acquisition uncertainty.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $27.87, down 3.46% over 24 hours and near its 52-week low. The stock shows a bearish technical trend with mixed sentiment; recent earnings have mostly beaten expectations, but Q2 2026 revenue growth missed and guidance was cut. Fundamentals are solid with revenue rising to $6.16B in 2025 and net income margin improving to 10.08%, though debt levels have increased. The company faces competitive pressures in key markets like U.S. Orthopaedics.

Outlook is cautious: valuation ratios like P/E of 18.96 are reasonable, but analyst consensus is Hold (65%) due to execution risks and CFO departure. Opportunities include innovation in surgical robotics and new product launches, but investors should monitor U.S. market weakness and debt management for sustained recovery.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MGM Resorts International

MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.

Read more on MGM

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN